Search
for
Sort by
Research 241–270 of 1000+
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Baricitinib: A Review in Severe Alopecia Areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Annual Convention in the Time of COVID
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Alopecia universalis. Partial response to tofacitinib
- One of the best treatments for alopecia areata remains unpublished
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Alopecia Areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Alopecia Areata: Current and Emerging Therapies
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study